07/2019 - 06/2021 — Bioinformatician, Allergy and Infectious Diseases, U. of Washington
08/2017 - 06/2019 — Post-doctoral research fellow, Microbiology & Immunology, U. of British Columbia
07/2016 - 06/2017 — Post-doctoral research associate, Bacteriology/Sociology, U. of Wisconsin-Madison
08/2011 - 06/2016 — Graduate research assistant, Bacteriology, U. of Wisconsin-Madison
08/2008 - 05/2011 — Undergraduate research assistant, Biology, U. of Puget Sound
2011 - 2016 — Ph.D. Microbiology, U. of Wisconsin-Madison, Madison, WI. GPA: 4.00
2007 - 2011 — B.S. Molecular and cellular biology, Minor mathematics, U. of Puget Sound, Tacoma, WA. GPA: 3.84
Dill-McFarland KA, Mitchell K, Batchu S, Segnitz RM, Benson B, Janczyk T, Cox MS, Mayanja-Kizza HA, Boom WH, Benchek P, Stein C, Hawn TR, Altman MC. 2023. kimma: Flexible linear mixed effects modeling with kinship for RNA-seq data. Bioinformatics. 39(5):btad279. doi: 10.1093/bioinformatics/btad279 — GitHub
Jackson DJ, Bacharier LB, Gergen PJ … Dill-McFarland KA … Altman MC, US NIAID Inner City Asthma Consortium. 2022. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet 400(10351): 502-511 doi: 10.1016/S0140-6736(22)01198-9
Dill-McFarland KA, Schwartz JT, Zhao H, Shao B, Fulkerson PC, Altman MC, Gill MA. 2022. Eosinophil-mediated suppression and Anti-IL-5 enhancement of plasmacytoid dendritic cell interferon responses in asthma. J Allergy Clin Immunol. Epub ahead of print. doi: 10.1016/j.jaci.2022.03.025 — GitHub
2017, 2018, 2019, 2022 — Session convener American Society for Microbiology (ASM) Microbe meeting
2016 — Microbiome Digest’s Best Microbiome Paper
2016 — Sigrid Leirmo Memorial Award for peer mentorship and support
2009, 2010 — American Society for Microbiology Undergraduate Fellow
University of Washington, Division of Allergy and Infectious Diseases
kadm [at] uw.edu
@kdillmcfarland